Investor Presentaiton

More than 90% of the top 20 largest global biopharma companies are clients of Eurofins * eurofins Eurofins biopharma locations Global CRO Market Outlook* Figure 1: The clinical CRO market will grow 7% (2015-2020E CAGR); outsourced penetration will go to 50% $35 60% $in bilions $31 $30 $29 55% $27 50% $25 50% $25 $24 $20 $19 $17 $18 $22 40% $22 45% 41% 40% $15 35% 34% 35% $10 $5 30% 25% $0 20% 2011 2012 2013 2014 2015 2016E 2017E 2018E 2019E 2020E Clinical CRO Market (loft axis) --Outsourced Penetration (right axis) Note: Clinical CRO market includes only Clinical, excludes Discovery, Preclinical, Central Laboratory, and Post-Approval/Commercialization *Source: CRO Industry Primer, 20 June 2016, Credit Suisse Eurofins' site map as of December 2020 Top 10 global biopharma companies** Johnson & Johnson (US) Roche (CH) Pfizer (US) Bayer (DEU) Novartis (CH) Merck (US) GlaxoSmithKline (UK) Sanofi (FR) AbbVie (US) Abbott (US) **Source: https://www.pharmapproach.com/top-10-pharmaceutical-companies-in-the-world/ 49

View entire presentation